Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Peter Mac Asaga has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Viral and host determinants of arboviral disease severity in African populations: A systematic review with meta-analysis

    by Peter Mac Asaga, Vijeesh Kadukkatti, Philomena Airiohuodion, Dakul Anthony Danaan, Dave C. Ibeh, Axel Kroeger

    Background: Arboviral diseases caused by dengue (DENV), chikungunya (CHIKV), yellow fever (YFV), Rift Valley fever (RVFV), and Zika (ZIKV) viruses are responsible for considerable morbidity and mortality across Africa. Clinical presentations range from self-limiting febrile illness to fatal haemorrhagic syndromes, encephalitis, and chronic arthropathy, yet the factors that govern who develops severe disease remain poorly defined in African settings. We set out to synthesise what is currently known about the viral and host immune determinants of clinical severity for all five arboviruses in African populations. Methods: PubMed/MEDLINE, Scopus, Web of Science, and the WHO Global Index Medicus were searched from database inception to 8 March 2026 for studies reporting clinical severity outcomes or viral or host immune determinants of DENV, CHIKV, YFV, RVFV, or ZIKV infections in African populations or populations of documented African ancestry. Eligibility followed a Population, Exposure, Comparison, Outcome (PECO) framework. Study quality was assessed using the Newcastle-Ottawa Scale (NOS), and the certainty of evidence for meta-analytic outcomes was evaluated using the GRADE framework. The protocol was registered prospectively on PROSPERO (CRD420261334251) on 7 March 2026, before the literature search commenced. The review was conducted in accordance with PRISMA 2020, and the completed checklist is provided as S2 Table. Results: We included 154 studies published between 1978 and 2026, covering 38 African and African-diaspora countries. DENV was the most frequently studied virus (n = 57), followed by RVFV (n = 31), multiple arboviruses (n = 27), CHIKV (n = 15), YFV (n = 15), and ZIKV (n = 9). Random-effects meta-analysis using Freeman-Tukey double arcsine transformation yielded a pooled RVFV case fatality rate of 16.9% (95% CI 11.6 to 22.8; I 2 = 88.4%, 19 studies) and a pooled DENV severe disease proportion of 8.5% (95% CI 3.0 to 16.2; I 2 = 95.7%, 10 African studies). Given the extreme heterogeneity in both analyses, these pooled estimates should be interpreted as approximate central tendencies of the available data rather than precise epidemiological parameters, and any comparison with reported Asian cohort figures must be made with considerable caution. The certainty of evidence for both pooled outcomes was rated as very low by GRADE criteria. Egger’s test indicated significant funnel plot asymmetry for RVFV (p < 0.001). Convergent cytokine dysregulation (elevated IL-6, IL-8, MCP-1, IP-10) characterised fatal RVFV and YFV. Preliminary, hypothesis-generating evidence for genetically mediated dengue protection in African-ancestry populations emerged from admixture mapping, Fc receptor polymorphism, and clinical severity comparisons, though direct validation in continental African cohorts is lacking. ZIKV clinical severity data from Africa were near-absent. Conclusions: Distinct immunopathological signatures are emerging for arboviral severity in African populations, including convergent cytokine dysregulation in fatal RVFV and YFV, preliminary evidence for genetically mediated dengue protection linked to African ancestry, and prolonged CHIKV arthropathy. The evidence base, however, remains heavily weighted towards descriptive epidemiology. Critical gaps, particularly the near-absence of clinical ZIKV data, limited cytokine and T-cell profiling, and the lack of prospective multi-site studies, must be addressed to inform vaccine deployment, clinical management, and pandemic preparedness on the continent.


  • Open Access

    Geography as an Independent Determinant and Immuno‐Inflammatory Correlates of Long‐Term Oral Cancer Survival: A Population‐Based Cohort Study From India

    by Nitika Taneja, Peter Mac Asaga

    Background: India contributes approximately one‐third of global oral cancer cases, with pronounced disparities in outcomes across geographic and socio‐economic strata. While rural–urban survival differences have been documented, limited evidence exists regarding whether geographic residence independently predicts long‐term survival. Methods: We conducted a retrospective population‐based cohort study using data from the Wardha Population‐Based Cancer Registry, Maharashtra, for oral cancer cases (ICD‐10 C00–C06) diagnosed between 2010 and 2022, with follow‐up through December 2024. Overall survival was analysed using Kaplan–Meier methods and Cox proportional hazards regression. A mechanistic extension incorporated systemic immune–inflammatory biomarkers derived from pretreatment laboratory values, including neutrophil‐to‐lymphocyte ratio, systemic immune–inflammation index, systemic inflammation response index, C‐reactive protein/albumin ratio and CRP–albumin–lymphocyte index. Results: Among 12,847 registered cancers, 1683 (13.1%) were oral cancers; 66.2% were rural residents. Five‐year survival was 42.1% for rural versus 56.3% for urban residents. Rural residence remained independently associated with mortality after adjustment for age, sex, education and clinical extent (HR 1.34, 95% CI 1.21–1.48). Rural patients demonstrated elevated inflammatory biomarkers and lower CRP–albumin–lymphocyte index. Sequential model adjustment demonstrated attenuation of the rural hazard ratio from 1.41 to 1.22. Conclusion: Geographic residence independently predicts long‐term oral cancer survival in this population‐based cohort. Systemic immune–inflammatory biomarkers are associated with survival and partially account for rural–urban disparities.

  • Open Access

    CHIKV-ZIKV Antibody Co-positivity and Preserved Neutralising Activity in a Nigerian Arboviral Study

    by Peter Asaga Mac, Axel Kroeger, Dave C. Ibeh, Chukwuma Anyaike, Philomena E. Airiohuodion, Dakul Anthony Danaan

  • Open Access

    Cytokine and endothelial injury signatures associated with severe dengue: a systematic review and meta-analysis integrating viral burden and host-response markers

    by Peter Mac Asaga, Axel Asaga Kroeger, Vijeesh Kadukkatti, Leo Arsha, Philomena Airiohuodion

    Summary Background Severe dengue reflects a temporally regulated interaction between viral burden, NS1 antigenaemia, cytokine and chemokine amplification, endothelial activation, glycocalyx injury, and organ stress. Although individual cytokines, endothelial markers, viral-burden measures, and clinical markers have been widely studied, the integrated pathogen-host evidence base remains fragmented. We synthesised evidence for cytokine, endothelial, and viral-burden signatures associated with severe dengue and assessed whether paired pathogen-host measurement provides a biologically coherent framework for severity assessment. Methods We searched MEDLINE, Embase, Scopus, Web of Science, Cochrane Library, Global Health, WHO Global Index Medicus, and medRxiv from database inception to 30 April 2026, without language restriction, for studies reporting viral burden, NS1 antigenaemia, cytokine, chemokine, endothelial, glycocalyx, inflammatory, or routine host-response markers in laboratory-confirmed dengue with severity outcomes. Eligible designs were prognostic-factor association studies, cross-sectional biomarker studies, and multivariable prediction-model studies. Risk of bias was assessed using QUIPS for prognostic-factor studies, PROBAST for prediction-model studies, and the relevant JBI critical appraisal checklist for cross-sectional biomarker studies, with the Newcastle-Ottawa Scale used selectively for cohort or case-control designs not amenable to QUIPS. Random-effects meta-analysis pooled standardised mean differences using restricted maximum likelihood with Hartung-Knapp adjustment. The protocol was registered with PROSPERO (CRD420261396923) before final extraction and synthesis. Findings Of 4,180 records identified, 79 studies including 47,612 participants met eligibility criteria. Forty-nine studies evaluated paired pathogen-host markers, 14 evaluated viral burden or NS1 antigenaemia alone, nine evaluated host biomarkers alone, and seven reported multivariable prediction models. Pathogen-side markers showed modest pooled severity associations whose magnitude depended on day of illness, immune status, and infecting serotype. Cytokine and chemokine markers, particularly IL-10, IL-6, IL-8, and CXCL10/IP-10, showed larger pooled effects favouring severe disease, while endothelial and glycocalyx markers, including angiopoietin-2 and syndecan-1, provided the most direct mechanistic link to plasma leakage. Routine clinical markers, especially platelet count, AST, ferritin, ALT, and lactate, retained substantial discriminatory value. Prediction models reported areas under the curve of up to 0·96 in internal validation and 0·97 in discovery analyses, but three had been externally validated, calibration was reported in two, and decision-curve analysis in none. Interpretation Current evidence supports severe dengue as an integrated pathogen-host injury syndrome in which viral burden and NS1 antigenaemia interact with cytokine amplification, endothelial dysfunction, glycocalyx injury, and routine markers of organ stress. The strongest translational direction is not a single biomarker but a parsimonious cytokine-endothelial-pathogen panel requiring prospective external validation across age groups, serotypes, immune-status strata, and endemic regions. Existing evidence supports candidate marker prioritisation and mechanistic synthesis, but not immediate routine clinical deployment.

  • Open Access

    CHIKV–ZIKV antibody co-positivity and preserved neutralising activity in Nigeria

    by Asaga Mac Peter, Axel Kroeger, Dave C. Ibeh, Chukwuma Anyaike, Philomena Airohuodion, Dakul Anthony Danaan

    Background. Arboviral coinfections complicate public health responses in endemic regions. Antibody-dependent enhancement (ADE) is a well-characterised phenomenon among related flaviviruses, yet its relevance to cross-family alphavirus–flavivirus interactions remains unclear. We examined patterns of CHIKV–ZIKV coinfection in a Nigerian cohort and asked whether the serological data were consistent with antibody-mediated or alternative mechanisms.Methods. We carried out serological surveillance of 871 participants across three ecological zones in Nigeria, measuring IgG and IgM responses to chikungunya virus (CHIKV), Zika virus (ZIKV) and dengue virus (DENV) by immunoblot. Functional antibody activity was assessed by plaque reduction neutralisation test (PRNT) in a subset of 150 sera. Observed-to-expected (O/E) co-positivity ratios were calculated under an assumption of immunological independence. Complementary computational analyses of viral envelope proteins were performed to flag molecular features that might inform future mechanistic work.Results. CHIKV–ZIKV IgG co-seropositivity was more frequent than expected under independence, with 151 observed co-positive samples against 108.33 expected (O/E = 1.39). Recent CHIKV–ZIKV IgM co-positivity showed a larger but numerically sparse enrichment, with 6 observed against 2.44 expected (O/E = 2.46), that is, roughly 2.5-fold more frequent than expected under immunological independence. Because subgroup overlap counts were not fully available in the aggregate tables, a bounded sensitivity analysis was performed. Across all allocations consistent with the reported marginals and the overall IgG overlap, the possible O/E range was 1.77 to 2.30 in HIV-positive participants and 0.89 to 1.07 in HIV-negative participants. For recruitment stream, the possible O/E ranges were 0.93 to 1.21 in blood donors and 1.34 to 1.61 in outpatients. PRNT showed preserved neutralising activity among the tested sera: CHIKV neutralisation in 76/97 (78.4%) CHIKV IgG-positive sera and ZIKV neutralisation in 20/29 (69.0%) ZIKV IgG-positive sera. Exploratory CD4-stratified analysis was possible only in the PRNT subset with available CD4 values and was descriptive, given very small denominators.Conclusions. These findings point to CHIKV–ZIKV antibody co-positivity in a heterogeneous Nigerian serosurvey, but the magnitude differs by antibody class and must be read cautiously. IgG co-seropositivity showed a modest excess, whereas the stronger 2.5-fold signal applied to recent IgM co-positivity and rested on only six co-positive samples. The PRNT data show preserved neutralising activity in the tested subset; the study does not directly test ADE. Exact subgroup and CD4-adjusted analyses should be prioritised should the original row-level dataset become available.

  • Open Access

    Host factors, inflammatory markers, and clinical outcomes of Naegleria fowleri meningoencephalitis

    by Vijeesh Kadukkatti, Brijil K. Mathew, Peter Mac Asaga

    Background: Primary amoebic meningoencephalitis (PAM) caused by Naegleria fowleri carries historical case fatality rates (CFR) exceeding 97%. The 2025 Kerala outbreak, the largest documented globally, provided an unprecedented opportunity to identify host factors and inflammatory correlates influencing survival under standardised management. Methods: We conducted a prospective observational study of 200 laboratory-confirmed PAM cases across six districts of Kerala, India (January–November 2025). All patients received protocolised amphotericin B ± miltefosine. Demographic, clinical, and laboratory data were collected, including inflammatory biomarkers (IL-6, TNF-α, IL-1β, neutrophil-to-lymphocyte ratio), pathogen burden (qPCR), and treatment timing. Multivariable logistic regression identified mortality predictors; bootstrap resampling and E-value sensitivity analyses assessed robustness. Results: Here we show that among 200 patients (median age 41 years; 50% male), 134 with resolved outcomes yield a CFR of 45·5% (95% CI 37·3–54·5%; 61 deaths, 73 recoveries). Diabetes mellitus is the only statistically significant predictor of mortality in the adjusted model (adjusted OR 2·59; 95% CI 1·01–6·66; p = 0·048), though the proximity of the lower confidence bound to unity warrants cautious interpretation. This association remains consistent across sensitivity analyses (bootstrap 95% CI 1·06–8·74; E-value 4·62). Asthma demonstrates a protective association in univariable analysis (OR 0·37; p = 0·021), though this finding remains hypothesis-generating. Early treatment (≤2 days) shows a trend toward improved survival ( p = 0·084). Inflammatory biomarkers show no association with outcome, though CSF pathogen burden correlates significantly with admission neurological severity. Conclusions: Under standardised treatment, diabetes mellitus emerges as a key host determinant of PAM mortality. The dissociation between inflammatory markers and outcomes suggests neurological fate may be determined early in infection, with immediate clinical implications as climate change expands the geographic range of N. fowleri .

  • Open Access

    Physical activity and hypertension amongst HIV-positive and HIV-negative populations in rural South Africa

    by Benjamin Zebita Mayasi, Peter Asaga Mac

    Hypertension represents a major public health challenge in sub-Saharan Africa, characterised by substantial underdiagnosis and inadequate management. This secondary analysis of cross-sectional survey data examined the association between physical activity patterns and hypertension prevalence amongst HIV-positive and HIV-negative populations in rural South African communities. Data were drawn from the ongoing Agincourt Health and Socio-Demographic Surveillance System Site (AHDSS), collected between August 2022 and May 2023, involving 4,436 participants aged ≥ 15 years. Physical activity was assessed using the Global Physical Activity Questionnaire (GPAQ) within the WHO STEPwise framework, and blood pressure was measured using an automated digital device (OMRON R6 wrist monitor). Statistical analyses employed chi-squared tests, two-sample t tests, and multivariable logistic regression models adjusting for demographic, anthropometric, metabolic, and behavioural confounders. Moderate physical activity was associated with lower odds of hypertension irrespective of HIV serostatus, supporting the integration of physical activity counselling into HIV care and primary healthcare services in resource-limited settings (adjusted OR = 0.74, 95% CI: 0.56–0.99, p = 0.043). Hypertension prevalence was 40.4% overall. HIV-positive males demonstrated higher prevalence (60.2%) compared with HIV-negative males (46.9%, p < 0.001). HIV-positive status was independently associated with increased odds of hypertension (adjusted OR = 1.45, 95% CI: 1.18–1.78). Age, male sex, obesity, elevated waist-hip ratio, and current alcohol consumption showed significant positive associations with hypertension. Moderate physical activity provides protective benefits against hypertension irrespective of HIV serostatus, supporting the integration of physical activity counselling into HIV care and primary healthcare services in resource-limited settings.